| Patent application number | Description | Published |
|---|
| 20080255152 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) wherein the variables X | 10-16-2008 |
| 20080269296 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) wherein the variables X | 10-30-2008 |
| 20090023785 | 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) or a pharmaceutically acceptable salt, enantiomer, racemate, diasteromers or mixtures thereof, or a solvate thereof, formulations and methods of use thereof, as opioid receptor antagonists are disclosed wherein the variables are as described herein. | 01-22-2009 |
| 20090186873 | KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST - A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions. | 07-23-2009 |
| 20100113579 | PRODRUGS OF EXCITATORY AMINO ACIDS - This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders. | 05-06-2010 |
| 20100197669 | KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST - A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions. | 08-05-2010 |
| 20110118251 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula: | 05-19-2011 |
| 20110207672 | METHODS OF TREATMENT USING A PRODRUG OF AN EXCITATORY AMINO ACID - This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders. | 08-25-2011 |
